Maria Isaac

2.0k total citations
27 papers, 873 citations indexed

About

Maria Isaac is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Pharmacology. According to data from OpenAlex, Maria Isaac has authored 27 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 9 papers in Economics and Econometrics and 6 papers in Pharmacology. Recurrent topics in Maria Isaac's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Dementia and Cognitive Impairment Research (5 papers) and Treatment of Major Depression (4 papers). Maria Isaac is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Dementia and Cognitive Impairment Research (5 papers) and Treatment of Major Depression (4 papers). Maria Isaac collaborates with scholars based in United States, United Kingdom and Netherlands. Maria Isaac's co-authors include Spiros Vamvakas, Elizabeth Molsen, Stefan Cano, Laurie B. Burke, Jeremy Hobart, Patrick Marquis, Donald L. Patrick, John H. Powers, Marc K. Walton and María C. Carrillo and has published in prestigious journals such as Nature Reviews Drug Discovery, Progress in Neurobiology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Maria Isaac

26 papers receiving 860 citations

Peers

Maria Isaac
Leigh Ann White United States
Miriam L. Zichlin United States
George Papadopoulos Greece
Lois G. Kim United Kingdom
Leslie E. Phillips United States
Emily O. Westbrook United States
Szofia Bullain United States
Andrew Greenspan United States
Sarah Acaster United Kingdom
Dingfen Han United States
Leigh Ann White United States
Maria Isaac
Citations per year, relative to Maria Isaac Maria Isaac (= 1×) peers Leigh Ann White

Countries citing papers authored by Maria Isaac

Since Specialization
Citations

This map shows the geographic impact of Maria Isaac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Isaac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Isaac more than expected).

Fields of papers citing papers by Maria Isaac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Isaac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Isaac. The network helps show where Maria Isaac may publish in the future.

Co-authorship network of co-authors of Maria Isaac

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Isaac. A scholar is included among the top collaborators of Maria Isaac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Isaac. Maria Isaac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isaac, Maria & Aisha K. Gill. (2025). Gender-based corruption: an exploration of sexual corruption in migration contexts in the UK. Journal of Gender-Based Violence. 1–30.
2.
Huang, Yangyang, et al.. (2020). Tropomyosin Receptor Kinase B Expressed in Oligodendrocyte Lineage Cells Functions to Promote Myelin Following a Demyelinating Lesion. ASN NEURO. 12(1). 1665534744–1665534744. 12 indexed citations
3.
Powers, John H., Donald L. Patrick, Marc K. Walton, et al.. (2017). Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force. Value in Health. 20(1). 2–14. 106 indexed citations
4.
Molinuevo, José Luís, Jordi Camı́, Xavier Carné, et al.. (2016). Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit. Alzheimer s & Dementia. 12(5). 614–622. 41 indexed citations
5.
Walton, Marc K., John H. Powers, Jeremy Hobart, et al.. (2015). Clinical Outcome Assessments: Conceptual Foundation—Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force. Value in Health. 18(6). 741–752. 180 indexed citations
6.
Haas, Manuel, Valentina Mantua, Marion Haberkamp, et al.. (2015). The European Medicines Agency's strategies to meet the challenges of Alzheimer disease. Nature Reviews Drug Discovery. 14(4). 221–222. 9 indexed citations
7.
Isaac, Maria & Christine Gispen‐de Wied. (2015). CNS biomarkers: Potential from a regulatory perspective. European Neuropsychopharmacology. 25(7). 1003–1009. 2 indexed citations
8.
Romero, Klaus, Kaori Ito, Ruolun Qiu, et al.. (2014). The future is now: Model‐based clinical trial design for Alzheimer's disease. Clinical Pharmacology & Therapeutics. 97(3). 210–214. 49 indexed citations
9.
Cedarbaum, Jesse M., Diane Stephenson, Richard A. Rudick, et al.. (2014). Commonalities and Challenges in the Development of Clinical Trial Measures in Neurology. Neurotherapeutics. 12(1). 151–169. 8 indexed citations
10.
Wied, Christine Gispen‐de, et al.. (2012). The placebo arm in clinical studies for treatment of Psychiatric Disorders: A Regulatory Dilemma. European Neuropsychopharmacology. 22(11). 804–811. 7 indexed citations
11.
Manolis, Efthymios, Spiros Vamvakas, & Maria Isaac. (2011). New pathway for qualification of novel methodologies in the European medicines agency. PROTEOMICS - CLINICAL APPLICATIONS. 5(5-6). 248–255. 30 indexed citations
12.
Kan, Gabor Abellán van, Jesse M. Cedarbaum, Matteo Cesari, et al.. (2011). Sarcopenia: Biomarkers and imaging (International Conference on Sarcopenia research). The journal of nutrition health & aging. 15(10). 834–846. 32 indexed citations
13.
Vamvakas, Spiros, et al.. (2011). On the edge of new technologies (advanced therapies, nanomedicines). Drug Discovery Today Technologies. 8(1). e21–e28. 9 indexed citations
14.
15.
16.
Hampel, Harald, Gordon Wilcock, Sandrine Andrieu, et al.. (2010). Biomarkers for Alzheimer's disease therapeutic trials. Progress in Neurobiology. 95(4). 579–593. 100 indexed citations
17.
Stoyanova‐Beninska, Violeta, Tamar Wohlfarth, Maria Isaac, et al.. (2010). The EU paediatric regulation:. European Neuropsychopharmacology. 21(8). 565–570. 11 indexed citations
18.
Isaac, Maria, et al.. (2005). Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care. Human Psychopharmacology Clinical and Experimental. 20(3). 207–210. 30 indexed citations
19.
Isaac, Michael T., et al.. (2003). Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency. Human Psychopharmacology Clinical and Experimental. 18(8). 595–601. 6 indexed citations
20.
Isaac, Maria, et al.. (2003). Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects. Human Psychopharmacology Clinical and Experimental. 18(7). 569–574. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leigh Ann White Breakdown of academic impact, for papers by Miriam L. Zichlin Breakdown of academic impact, for papers by George Papadopoulos Breakdown of academic impact, for papers by Lois G. Kim Breakdown of academic impact, for papers by Leslie E. Phillips Breakdown of academic impact, for papers by Emily O. Westbrook Breakdown of academic impact, for papers by Szofia Bullain Breakdown of academic impact, for papers by Andrew Greenspan Breakdown of academic impact, for papers by Sarah Acaster Breakdown of academic impact, for papers by Dingfen Han
Rankless by CCL
2026